Tag Archives: New York Times

Elmendorf Refuses to Go Quietly Into the Night of HCR

By Pharm Exec | Published: June 9, 2010
Guest Blog by Tom Norton of NHD Smart Communications. You can reach him at tnorton@nhdcomm.com. Amidst all the gurgling of oil last week(bad! bad! bad!), a competing thunderstorm of words erupted as Doug Elmendorf, Director of CBO, had the temerity to revisit the real costs of the new HCR law. Addressing something that, for whatever reason, [...]
Posted in Guest Blog | Also tagged , , , , , , | 2 Comments

When Big Pharma Leaves Town

By Walter Armstrong | Published: November 16, 2009
Image via Wikipedia Wall Street smiles when a drug company gets with the program by “restructuring” and “rightsizing”—cutting costs through headline-grabbing layoffs. But for Main Street, the story of hundreds or thousands of sales reps, say, and researchers getting kicked to the curb is quite different. The two gi-normous mergers that closed in the past month offer [...]
Posted in Strategy | Also tagged , , , , , , | 2 Comments

Tauzin to Boehner: Don’t “Bully” Me

By Walter Armstrong | Published: August 19, 2009
Image via Wikipedia PhRMA chief Billy Tauzin so far shows no sign of waving the white flag in response to an accusatory missive from House Minority Leader Rep. John Boehner bludgeoning his former Republican colleague for leading the drug industry’s support of President Obama’s healthcare reform effort. Pointedly CC’d to pharma CEOs – Tauzin’s employers—and simultaneously [...]
Posted in Regulatory | Also tagged , , , , , , | Leave a comment